Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bridgette McCabe

Vascular & Interventional Radiology Galloway, NJ Medical Doctor

NPI 1790164614 CMS profile 1354816

44 E Jimmie Leeds Rd Ste 101, Galloway, NJ 08205

Open in the dashboard

General payments

$7,092

57 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bridgette McCabe of Galloway, NJ is reported in the CMS Open Payments database as having received $7,092 across 57 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $626 10
2024 General $2,199 12
2023 General $2,362 17
2022 General $1,261 11
2021 General $316 3
2019 General $328 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bridgette McCabe
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Bridgette McCabe were reported at $626. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Bridgette McCabe Vascular & Interventional Radiology median Middle half National median
2019 $328 $422 $125–$1,555 $163
2020 $0 $200 $68–$652 $114
2021 $316 $280 $99–$866 $132
2022 $1,261 $433 $137–$1,497 $149
2023 $2,362 $506 $152–$2,019 $160
2024 $2,199 $556 $175–$1,930 $164
2025 $626 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $2,475 14 payments
  2. Abbott Laboratories $1,721 12 payments
  3. Terumo Medical Corporation $1,173 12 payments
  4. Shockwave Medical, Inc $329 2 payments
  5. Penumbra, Inc. $310 2 payments
  6. Inari Medical, Inc. $199 2 payments
  7. W. L. Gore & Associates, Inc. $189 1 payment
  8. Argon Medical Devices, Inc. $174 1 payment
  9. Bard Peripheral Vascular, Inc. $174 2 payments
  10. Cook Medical LLC $108 1 payment
  11. Other $240 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,796 44 payments
  2. Travel and Lodging $3,296 13 payments
Products named General payments · program years 2019–2025
  1. EkoSonic $1,696 7 payments
  2. SUPERA $1,650 10 payments
  3. TR BAND $616 3 payments
  4. GLIDESHEATH SLENDER $523 9 payments
  5. FLOWTRIEVER CATHETER, S $368 3 payments
  6. Indigo System $310 2 payments
  7. TheraSphere Y90 Glass Microspheres 10 GBq $205 2 payments
  8. EXCLUDER Conformable AAA Endoprosthesis with Active Control $189 1 payment
  9. OPTION $174 1 payment
  10. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $168 1 payment
  11. Other $1,779 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 168 billing codes

Paid by Medicare

$255,242

Of which drugs: $1,719

Medicare patients

869

Average age 75

Services billed

9,524

465 women, 404 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Ischemic heart disease 48%
Diabetes 47%
Chronic kidney disease 37%
Heart failure 29%
COPD 29%
Atrial fibrillation 28%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 53 7,865 $777
Injection, cefazolin sodium, 500 mg J0690 Office 14 56 $35
Injection, fentanyl citrate, 0.1 mg J3010 Office 18 24 $18

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

57 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record